Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancy

Khalili, Sammy; Worrall, Douglas M; Brooks, S.C.; Morris, Shane; Farquhar, Douglas R.; Newman, Jason G.; Learned, Kim O.; Ahn, Peter H.; Craig, John R.; Kennedy, David W.; O’Malley, Bert W.; Palmer, James N.; Adappa, Nithin D.

doi:10.1002/hed.24413

Cited by 20 publications

(49 citation statements)

References 18 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Out of the imaging modalities, magnetic resonance imaging (MRI) had the highest PPV at 84%, significantly higher than computed tomography (CT) (44%) and positron emission tomography (PET)/CT (46%). However, PET/CT was critical in diagnosing distant recurrences in cases of mucosal melanoma . Furthermore, the presence of suspicious symptoms significantly increased the PPV of endoscopy and imaging to 83% and 90%, respectively, compared to 13% and 55%, respectively, without suspicious symptoms …”

Section: Literature Reviewmentioning

confidence: 99%

“…However, PET/CT was critical in diagnosing distant recurrences in cases of mucosal melanoma . Furthermore, the presence of suspicious symptoms significantly increased the PPV of endoscopy and imaging to 83% and 90%, respectively, compared to 13% and 55%, respectively, without suspicious symptoms …”

Section: Literature Reviewmentioning

confidence: 99%

“…Sinonasal malignancies are rare, representing only 3% of all head and neck neoplasms and approximately 1% of all malignancies . Given this low incidence and the diversity of pathologies, standardized protocols for post‐treatment surveillance are lacking.…”

Section: Introductionmentioning

confidence: 99%

“…Given this low incidence and the diversity of pathologies, standardized protocols for post‐treatment surveillance are lacking. Due to their advanced stage at presentation, sinonasal malignancies often have a poor prognosis, with recurrence rates ranging from 27% to 56% . Whereas the majority of recurrences occur within 2 to 3 years post‐treatment, certain malignancies, such adenoid cystic carcinoma, olfactory neuroblastoma, and melanoma, have a propensity to recur much later .…”

Section: Introductionmentioning

confidence: 99%

“…Sinonasal malignancies are rare, representing only 3% of all head and neck neoplasms and approximately 1% of all malignancies. 1 Given this low incidence and the diversity of pathologies, standardized protocols for post-treatment surveillance are lacking. Due to their advanced stage at presentation, sinonasal malignancies often have a poor prognosis, with recurrence rates ranging from 27% to 56%.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

What is the appropriate timing for endoscopic and radiographic surveillance following treatment for sinonasal malignancies?

et al. 2017

Self Cite

View full text Add to dashboard Cite

Section: Literature Reviewmentioning

confidence: 99%

Section: Literature Reviewmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

What is the appropriate timing for endoscopic and radiographic surveillance following treatment for sinonasal malignancies?

et al. 2017

Self Cite

View full text Add to dashboard Cite

Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi‐institutional study

Workman

Velasquez

Khan

et al. 2019

Int Forum Allergy Rhinol

View full text Add to dashboard Cite

BackgroundSinonasal malignancies are a rare subset of head and neck tumors, and surveillance strategies after definitive tumor treatment are often generalized from those for overall head and neck cancer outcomes data. However, recent literature suggests that the posttreatment period in sinonasal cancer is fundamentally different and a more tailored surveillance approach may be beneficial. Although rates of symptomatology are high in head and neck cancer recurrence and patient‐driven follow‐up is common, rates of symptomatology are unknown in sinonasal cancer specifically.MethodsPatients with recurrence of sinonasal malignancy were identified at 3 academic rhinology and skull base surgery centers. Demographic, tumor, and treatment data were collected. Rates of symptomatology at presentation were tabulated and examined in the context of several other variables.ResultsFifty‐five patients had recurrence of sinonasal malignancy after definitive treatment. Fifty‐one percent of patients had no suspicious symptoms at the time of tumor recurrence, with an average time to recurrence of 33 months. Male patients and patients with stage IVA or lower disease were significantly more likely to be asymptomatic at the time of recurrence (p < 0.05).ConclusionPatients with sinonasal malignancy have a much lower rate of symptomatology during tumor recurrence than that observed in head and neck cancer overall. Furthermore, time to recurrence is substantially longer, as a majority of head and neck cancer recurrences occur in the first 12 months after treatment. These differences highlight the need for more tailored surveillance paradigms in asymptomatic patients with a history of a definitively treated sinonasal neoplasm.

show abstract

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Kuan

Wang

Adappa

et al. 2024

Int Forum Allergy Rhinol

Self Cite

View full text Add to dashboard Cite

BackgroundSinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represents a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology‐based topics spanning the field.MethodsIn accordance with prior ICAR documents, ICSNT assigned each topic as an Evidence‐Based Review with Recommendations, Evidence‐Based Review, and Literature Review based on level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses format, and completed sections underwent a thorough and iterative consensus‐building process. The final document underwent rigorous synthesis and review prior to publication.ResultsThe ICNST document consists of 4 major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology‐based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.ConclusionAs an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.This article is protected by copyright. All rights reserved

show abstract

Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancy

Cited by 20 publications

References 18 publications

What is the appropriate timing for endoscopic and radiographic surveillance following treatment for sinonasal malignancies?

What is the appropriate timing for endoscopic and radiographic surveillance following treatment for sinonasal malignancies?

Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi‐institutional study

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Contact Info

Product

Resources

About